All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported Terminated | 2008-002662-56 | Preoperative administration of controlled-release oxycodone vs morphine as transition oppioid for TIVA in pain control post VATS | 2010-01-15 | due-trials |
Completed, but no date | 2008-002697-35 | A dose-finding study of Docetaxel, Oxaliplatin and Capecitabine (TEX) as First-Line Treatment in Patients with Advanced Gastric Cancer | bad-data | |
Completed, but no date, and reported results | 2008-003925-17 | Immunotherapy by autologous peripheral blood mononuclear cells and GM-CSF for hepatocellular carcinoma undergoing radiofrequency thermal ablation | bad-data | |
Not reported Terminated | 2008-004138-26 | USE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS | 2008-10-08 | due-trials |
Reported results | 2008-007287-42 | Ivabradine in multislice CT: comparison with metoprolol in the reduction of motion artefacts and in the improvement of diagnostic care. | 2010-09-30 | due-trials |
Completed, but no date Terminated | 2008-007353-12 | METHOTREXATE AS STEROID-SPARING AGENT IN IDIOPATHIC RETROPERITONEAL FIBROSIS: A MULTICENTRE RANDOMISED CONTROLLED TRIAL | bad-data | |
Completed, but no date | 2009-013004-31 | Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study includ... | bad-data | |
Completed, but no date, and reported results | 2009-013198-16 | Acute Myocardial Infarction and endothelial function. Assessment with a non invasive ultrasonographic computerized method during oral vitamin C supplementation. | bad-data | |
Completed, but no date, and reported results | 2009-016686-28 | Evaluation of [18F]Fluorocholine PET/CT imaging for staging and restaging of prostate cancer | bad-data | |
Completed, but no date | 2010-018853-36 | Switching from beta blocker monotherapy to either ganfort � or cosopt �. A three months, single-blind , parallel group, randomized clinical trial in ocular hypertension/primary open angle glaucoma. | bad-data | |
Completed, but no date Terminated | 2010-020010-28 | EVALUATION OF RESPIRATORY MUSCLES` FUNCTION IN PATIENTS AFFECTED BY ALS WITH HEAVY METAL POISONING | bad-data | |
Not reported Terminated | 2011-002719-27 | GLUCOSE METABOLISM AND INFLAMMATORY PARAMETERS UNDER IGF-I TREATMENT IN CYSTIC FIBROSIS METABOLISMO GLUCIDICO E PARAMETRI INFIAMMATORI DURANTE TRATTAMENTO CON RHIGF-I NELLA FIBROSI CISTICA | 2013-11-15 | due-trials |
Completed, but no date | 2011-002911-27 | Effect of boceprevir therapy on HCV-specific T cell responses: perspectives of immune monitoring and immune therapy Effetto della terapia con boceprevir sulle risposte T linfocitarie di HCV-specifi... | bad-data | |
Ongoing | 2011-006302-28 | Dopamine modulation of oxytocin prosocial effects Modulazione dopaminergica dell'effetto prosociale dell'ossitocina | not-yet-due | |
Not reported Terminated | 2012-004138-41 | Anti-viral T cell responses in patients with chronic HCV infection treated with telaprevir: can therapy induce functional T cell reconstitution? Risposte T-linfocitarie HCV-specifiche in pazienti c... | 2015-09-15 | due-trials |
Not reported | 2012-005399-32 | Randomized, open label, two parallel arms, intervention trial comparing the effect of DPP-IV inhibitor Vildagliptin vs. Glibenclamide on circulating EPCs. Trial di intervento monocentrico, randomiz... | 2016-06-10 | due-trials |
Completed, but no date | 2014-000574-19 | Experimental study for the evaluation of the effect of radioactive iodine therapy on free thyroxine circulating levels after oral administration of sodium levo-thyroxine in patients thyroidectomized ... | bad-data | |
Completed, but no date Terminated | 2014-001207-42 | Multicenter randomized trial comparing erlotinib vs mono-chemotherapy in the third-line treatment of non-small cell lung cancer (NSCLC) patients with EGFR-mutated or unknown Studio randomizzato mul... | bad-data | |
Completed, but no date Terminated | 2014-001303-52 | Treatment of relapsed/refractory leukemia with intravenous administration of Dacarbazine Trattamento della leucemia acuta mieloide recidivata/refrattaria con somministrazione endovenosa di Dacarbaz... | bad-data | |
Ongoing | 2014-003894-41 | Effect of a Peg-interferon alfa 2A pulse on HBV-specific T cell responses in chronic hepatitis HBeAg negative patients under long-term nucleos(t)ide treatment Effetto di Peginterferone alfa-2a sull... | not-yet-due | |
Completed, but no date Terminated | 2014-004395-28 | Phase II randomized study of maintenance regorafenib vs placebo in no progression patients after first-line platinum and fluoropyrimidines based chemotherapy in HER2 negative locally advanced/metastat... | bad-data | |
Not reported | 2015-001850-13 | Long-acting exenatide: a tool to stop cognitive decline in patients with mild cognitive impairment with or without dysglycemia? Exenatide a lunga durata di azione: un possibile strumento nel rallen... | 2018-03-23 | due-trials |
Completed, but no date | 2015-003024-31 | Anti-viral responses in patients with chronic HCV infection treated with DAA alone or with PEG-IFN based regimens Risposte anti-virali in pazienti con epatite cronica C trattati con DAA da soli o i... | bad-data | |
Completed, but no date Terminated | 2017-001429-41 | “TOCIlizumab for difficult-to-treat RETroperitoneal fibrosis. TOCIRET Trial” “TOCilizumab come terapia per i casi di fibrosi RETroperitoneale idiopatica difficili da trattare. Studio TOCIRET” | bad-data | |
Completed, but no date | 2020-001258-23 | COLCHICINE TO COUNTERACT INFLAMMATORY RESPONSE IN COVID-19 PNEUMONIA COLCHICINA PER CONTRASTARE LA RISPOSTA INFIAMMATORIA IN CORSO DI POLMONITE DA COVID 19 | bad-data |